The novel approach of this peptide represents a significant development in the handling of type 2 diabetes. Unlike existing medications, tirzepatide affects two pathways – GLP-1 and glucose-dependent insulinotropic https://tirzepatidepeptide691077.fitnell.com/83135895/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment